Skip to main content
. 2017 Nov 8;5(11):E1136–E1143. doi: 10.1055/s-0043-118829

Table 1. Demographic data.

Diagnostic categories * Total (n = 136)
Group 1 (n = 95) Group 2 (n = 22) Group 3 (n = 19)
Mean Age (range) 67.6 (38 – 83) 56.4 (28 – 76) 62.8 (35 – 80) 65.1 (28 – 83)
Gender (female) (%) 38 (39.6 %) 16 (72.7 %)  4 (21.1 %) 54 (39.7 %)
Size of tumor (mm) (range) 28.9 (4 – 110) 23.2 (8 – 51) 25.8 (8 – 59) 27.6 (4 – 110)
Tumor location

  • Head

 62  8 13 83

  • Body

 26  7  5 38

  • Tail

  7  7  1 15
Diagnostic method

  • surgery

 64 (66.7 %) 20 (90.1 %)  8 (42.1 %) 91

  • FNA

 29 (30.2 %)  1 (4.5 %) 11 (57.9 %) 41

  • biopsy

  3 (3 %)  1 (4.5 %)  0  4
Diagnosis

  • adenocarcinoma 87 (91.6 %)

  • adenosquamous carcinoma 2 (2.1 %)

  • carcinoma arised from intraductal papillary mucinous carcinoma 6 (6.3 %)

  • PNET 22

  • AIP 12 (63.2 %)

  • mass forming chronic pancreatitis 4 (21.1 %)

  • granuloma 3 (15.8 %)
*

Group 1 adenocarcinoma, Group 2 pancreatic neuroendocrine tumor, Group 3 inflammatory pseudotumor, including autoimmune pancreatitis and mass forming chronic pancreatitis